Andriana Margariti

      Dr Andriana Margariti

      Senior Lecturer

      Phone: +44 (0)28 90634306, +44 (0)28 9097 6476

      For media contact email
      or call +44(0)2890 973091.

      View graph of relations

      Research Interests


      Dr Margariti has developed significant expertise in stem cell biology, with particular emphasis on cell reprogramming, chromatin remodelling, cell signalling and endothelial cell biology. Her postdoctoral training was in the Cardiovascular Division of the BHF Centre of Excellence at King’s College London (KCL). In 2013 she has been appointed as a Lecturer in the Centre of Experimental Medicine (CEM) in Queen’s University Belfast (QUB), and promoted to Senior Lecturer in 2017. Dr Margariti is working in the CEM which provides a vibrant and growing research centre focused on vascular biology. The Centre has now moved into a purpose-designed £32M Research building (~4,742m2) partly funded by a Wellcome Trust-Wolfson Capital Award. Dr Margariti has published a number of high-quality papers, and the impact of her research has been recognised by several prestigious awards, including the PAPANIKOLAOU Prize from the Hellenic Medical Society for significant contribution to medical research and the prize for outstanding performance and scientific research awarded by the KCL. Dr Margariti has been awarded a BBSRC new Investigator Award and  Grants from BHF to study the underlying mechanisms of direct reprogramming and endothelial cells in the context of vascular disease and diabetes. She has also established collaborations with two of the leading cell reprogramming laboratories in the world. Prof Deepak Srivastava in University of California, San Francisco (UCSF), who is internationally renowned for his studies in cell reprogramming, and Prof George Daley, the Director of the Stem Cell Transplantation Program at Children’s Hospital Boston in Harvard Medical School, whose group are world leaders in the studies in development and cellular reprogramming.

      Dr Margariti’s research program is based on the remarkable approach of direct reprogramming which will allow her to realise fundamental principles of cell reprogramming and establish homogeneous populations of endothelial cells. Damage to endothelial cells is a hallmark of the onset of vascular disease (including cardiovascular diseases and diabetic complications) which is a leading cause of mortality and morbidity worldwide. Cell therapy strategies that aim to recover vascular function are being increasingly explored as viable therapeutic avenues. Development of fast and robust new methodologies that produce well-characterised, homogenous, clinical-grade cells suitable for tissue repair/re-modelling would have great utility. Her research team have generated patient-specific iPS cells and PiPS cells and they now have exciting novel data and they are working towards to develop a remarkable new highly efficient strategy of cell reprogramming. Importantly, the potential of the reprogrammed endothelial cells to enhance angiogenesis and neovascularisation and to promote perfusion of ischemic tissue will be established.

      Dr Margariti’s research will demonstrate the therapeutic potential of “re-born” reprogrammed endothelial cells which would have transforming consequences for regenerative and personalised medicine.

      The road to novel regenerative therapy using direct reprogramming approaches will be challenging and hard, but the journey has already begun...



      Selected Awards



      2013    First Contact Initiative Grant from the European Society of Cardiology.

      2012    Prize for outstanding performance and scientific research awarding from the Cardiovascular Division, BHF Centre King’s College London UK.

      2012    PAPANIKOLAOU Prize for significant contribution to Medical research awarding from the Hellenic Medical Society in London, UK. 

      2011    Travel award for best abstract submitted, from the ESC council, 6th European Meeting for Vascular Biology & Medicine 21-24 September Krakow, Poland.

      2008    Michael Davies Young Investigator Award Finalist presenter. Spring Meeting 3-4 April Oxford, UK.

      2007    First prize for best poster presentation, European Vascular Genomic Network (EVGN), Sweden.

      2006    First prize for best poster presentation, European Vascular Genomic Network (EVGN), Sicily.

      2006    Best Log Book during PhD studies, St. George’s University of London, UK.



      Invited Speaker


      2017 Invited Speaker, 27th October at King’s College London

      2017 9th Annual Conference on Stem Cell and Regenerative MedicineSep 25-26, 2017, Berlin, Germany.

      2017 Invited Speaker, 22nd August at National University of Ireland, Galway.

      2016 Small Artery Network (SmArt) Vascular Progenitors in Biology and Medicine conference, November 7th to 9th, University of Fribourg, Switzerland.

      2016 Invited speaker to 2nd Annual International Symposium of Diabetes in ATINER, 2nd May 2016, Athens Greece.

      2015 Invited Speaker to BHF Panel, 14th December 2015 in King’s College London.

      2015 Invited Speaker at University of Strathclyde.

      2014 St George’s London University, Invited Lecture; “Stem Cells, Cardiovascular Disease and Regenerative Medicine”.

      2013 In Gladstone Institute of Cardiovascular Research in University of California, San Francisco (UCSF), 15th November 2013, a talk “on Cell Reprogramming and Regenerative Medicine”.

      2013 Atherosclerosis Gordon Research Conference (GRC) in Stowe, Vermont, USA, at the Stoweflake Resort and Conference Center, June 16-21, a talk on “Epigenetic therapies in cardiovascular disease”.

      2013 St George’s London University, Lecture on Stem Cells and Regenerative Medicine, 20th March 2013, London, UK

      2013 BHF Centres of Excellence Synergy Meeting, 4th February 2013, Oxford, UK. A talk on “Cell Reprogramming”.

      2012 Guest invitation in 3rd Annual “Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine 2nd Oct, Stevenage Bioscience Catalyst, Stevanage, UK.

      2012 Small Artery Network (SmArt) Vascular Progenitors in Biology and Medicine conference, September 13-15, University of Fribourg, Switzerland.

      2012 European Workshop on Proteomics and Vascular Biology, March 27th-29th, King’s College London, UK.


      Professional Registration


      2012-present         Member of International Society of Stem cell Research

      2009-present         Member of British Society for Cardiovascular Research 

      2008-present         Early Career member of American Heart Association

      2004-present         Member of Institute of Biomedical Science

      2003-present         Associate member of Royal Society of Chemistry

      2003-present         Member of the Biochemical Society




      Professional Development:


      • PGCHET
      • Associate Fellow of the Higher Education Academy (AFHEA); Recognition Reference: PR064209 17/12/2013
      • Postgraduate Certificate in Academic Practice in Higher Education Module Enhancing Academic Practice (7TTY0023) awarded from King’s College London November 2013.




       Developmental Studies BMS3003

      • Stem cells
      • Epigenetics
      • Short and Long Non-Coding RNAs


      MRes SCM8063: Cardiovascular Biology and Disease

      • Genetically Modified Animals in Cardiovascular Research
      • Atherosclerosis


      MRes SCM8064: Translational Cardiovascular Medicine

      • Stem Cell Biology 2
      • Regenerative Medicine


       MED1013 Foundations of Clinical Practise I

      •  Biochemistry Lectures



      • Problem solving with Genes, Molecules and Processes
      • Problems in Clinical Genetics
      • Problems in Biochemical Medicine


      Vascular Biology BMS3027




      Current Projects


      1. Generation of Induced Pluripotent Stem cells from Blood cells based on Novel Methods

      a. From Healthy Volunteers

      b. From Patient-Specific Groups


      2. Elucidation of the Mechanisms of Vascular Cell Differentiation

      a. RNA Binding Proteins

      b. Regulation of mRNA Splicing

      c. Small Peptides


      3. Establishing Robust Direct Reprogramming approaches towards Vascular Cell lineages

      a. Transcriptional Regulation

      b. Epigenetic Modulation

      c. Metabolic Switch


      4. Regenerative Medicine; Test the functional Properties of the Reprogrammed Vascular Cells in vivo and propose potential therapeutic strategies to treat Vascular Disease

      a. Angiogenesis

      b. Ischemia

      c. Vascular Injury/ Myocardial Infarction

      d. In vivo Reprogramming



      Group Members


      Research Fellows


      • Dr Chunbo Yang 2017-present

      Project: Endothelial dysfunction in Diabetic patients and Induced Pluripotent Stem Cells


      • Dr Letizia Gulino 2015-2016

      Project: Investigate the Underlying Mechanisms of Direct Reprogramming towards Vascular Cell Lineages


      • Dr Sophia Kelaini 2014-Present

      Project: Direct reprogramming towards Vascular Cell lineages; A Merging Approach


      PhD Students


      • Miss Magdalini Eleftheriadou 2017-Present

      Project: Investigate the role of non-coding RNAs during Endothelial cells differentiation from Induced Pluripotent Stem Cells.


      • Miss Rachel Caines 2015-Present

      Project: Dedifferentiated or re-Born Again? Elucidating the chromatin remodelling mechanisms during endothelial cell reprogramming for cardiovascular therapy (BHF Studentship)


      • Miss Marta Vilà-González 2014-Present

      Project: Diabetic macular oedema: insight into the disease and iPSC for the stratifications of its treatment based on novel technologies


      • Dr Amy Cochrane 2013-2016

      Project: Mechanisms of vascular cell differentiation from induced Pluripotent stem Cells (iPS cells); RNA binding Proteins


      MRes Students


      • Mr Corey Magee 2016-2017

      Project: Combining Induced Pluripotent Stem Cells and RNA Sequencing Technologies to Identify Novel Mediators of Endothelial Differentiation and Dysfunction


      • Mr Thomas Noteman 2014-2015

      Project: Elucidate the Unique Epigenetic Signature of reprogramming endothelial cells derived from Induced Pluripotent Stem Cells for use in Cardiovascular Therapy and Personalised Medicine


      • Mr Philip McCaughey 2013-2014

      Project: Mechanisms of vascular cell differentiation; Regenerative Medicine


       MSci Students


      • Miss Wiktoria Ratajczak 2017-2018
      • Miss Anya Harris 2016-2017
      • Miss Charlotte McBrien 2016-2017


      Undergraduate Supervision


      • Miss Jasmyn Ferson 2017-2018 
      • Miss Shannon O' Doherty (Intercalated BSc) 2017-2018
      • Mr Ryan Sterritt (Intercalated BSc) 2016-2017
      • Miss Marianna Tsifaki Erasmus / Technician 2016-Present 
      • Miss Fiona Cunningham 2015-2016

      • Miss Emma Martelli 2015-2016

      • Miss Daiana Drehmer (Science without Borders programme) 2015-2016

      • Mr Andrew Carmichael 2015-2016

      • Mr Peter Crossley (Intercalated BSc) 2015-2016

      • Mr Sean Mc Mahon (Intercalated BSc) 2014-2015

      • Miss Karin Yeoh 2014-2015

      • Mr Wilson Cheah (Intercalated BSc) 2013-2014


      Summer Students


      • Michael Breen (Nuffield Research Placement) 2017
      • Miss Azah Kadir 2015

      • Miss Medine Gumustas (Erasmus Student) 2015

      • Mr Gabriel Pena Machado (Science without Borders programme) 2015

      • Miss Rachel Caines 2014

      • Miss Rebekah Craig (Nuffield Research Placement) 2014





      Prof Alan Stitt Centre for Experimental Medicine Queen’s University Belfast, UK

      Dr David Grieve Centre for Experimental Medicine, Queen’s University Belfast, UK

      Prof Noemi Lois Clinical Professor Centre for Experimental Medicine, Queen’s University Belfast, UK

      Dr Sandra McAllister Clinical Lecturer Centre for Experimental Medicine, Queen’s University Belfast, UK

      Prof George Daley Boston Children’s Hospital Harvard Medical School, Boston, USA

      Dr Thorsten Schlaeger Head of pluripotent stem cells Core Facility Boston Children’s Hospital Harvard Medical School, USA

      Prof Deepak Srivastava Gladstone Institute of Cardiovascular Research in University of California, San Francisco, USA

      Dr Alisha Holloway (Bioinformatics Core) Gladstone Institute of Cardiovascular Research in University of California, San Francisco, USA

      Prof Qingbo Xu BHF Centre of Excellence King’s College London, UK

      Dr Lingfang Zeng BHF Centre of Excellence King’s College London, UK

      Dr Anna Zampetaki BHF Centre of Excellence King’s College London, UK

      Prof John McCarron  University of Strathclyde, Glasgow, UK

      Dr Steve Shnyder Institute of Cancer Therapeutics University of Bradford, UK















      Frequent Journals

      • Arteriosclerosis Thrombosis and Vascular Biology

        ISSNs: 1079-5642

        Additional searchable ISSN (Electronic): 1524-4636

        Lippincott Williams and Wilkins

        Scopus rating (2016): CiteScore 5.28 SJR 3.419 SNIP 1.608


      • Journal of biological chemistry

        ISSNs: 0021-9258

        Additional searchable ISSN (Electronic): 1083-351X

        American Society for Biochemistry and Molecular Biology Inc.

        Scopus rating (2016): CiteScore 4.17 SJR 2.755 SNIP 1.125


      • Stem Cells

        ISSNs: 1066-5099

        Additional searchable ISSN (Electronic): 1549-4918

        AlphaMed Press

        Scopus rating (2016): CiteScore 5.64 SJR 2.88 SNIP 1.329


      • American Journal of Physiology - Cell Physiology

        ISSNs: 0363-6143

        Additional searchable ISSN (Electronic): 1522-1563

        American Physiological Society

        Scopus rating (2016): CiteScore 3.09 SJR 1.765 SNIP 1.054


      • Circulation Research

        ISSNs: 0009-7330

        Additional searchable ISSN (Electronic): 1524-4571

        Lippincott Williams and Wilkins

        Scopus rating (2016): CiteScore 8.14 SJR 5.735 SNIP 2.457


      View all »

      ID: 2506301